4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-032499
President & CEO sold 100,000 shares at an average $33.00 ($3,300,000)
- President & CEO acquired 100,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-05-21 | Option exercise | +33,333 | $7.21 | $240,331 | 328,659 | D: show line 1 in the form |
| ROBIN HOWARD W President & CEO | 2019-05-21 | Sale | −33,333 | $32.93 | $1,097,656 | 295,326 | D: show line 2 in the form |
| ROBIN HOWARD W President & CEO | 2019-05-22 | Option exercise | +33,334 | $7.21 | $240,338 | 328,660 | D: show line 3 in the form |
| ROBIN HOWARD W President & CEO | 2019-05-22 | Sale | −33,334 | $33.38 | $1,112,689 | 295,326 | D: show line 4 in the form |
| ROBIN HOWARD W President & CEO | 2019-05-23 | Option exercise | +33,333 | $7.21 | $240,331 | 328,659 | D: show line 5 in the form |
| ROBIN HOWARD W President & CEO | 2019-05-23 | Sale | −33,333 | $32.69 | $1,089,656 | 295,326 | D: show line 6 in the form |
| Open-market sales · 100,000 sh · avg $33.00 · $3,300,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBIN HOWARD W President & CEO | 2019-05-21 | Option exercise · Common Stock | −33,333 | 66,667 | D: show line 7 in the form | |||||
| ROBIN HOWARD W President & CEO | 2019-05-22 | Option exercise · Common Stock | −33,334 | 33,333 | D: show line 8 in the form | |||||
| ROBIN HOWARD W President & CEO | 2019-05-23 | Option exercise · Common Stock | −33,333 | 0 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…